Mircea Ioan Alexandru Bistriceanu

Mr. Mircea Ioan Alexandru Bistriceanu

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
SBStefan Bogdan
Stefan Bogdan
Mircea Ioan Alexandru BistriceanuMircea Ioan Alexandru Bistriceanu
Mircea Ioan Alexandru Bistriceanu
Cosmin Gabriel UrsuCosmin Gabriel Ursu
Cosmin Gabriel Ursu
AAAndrei Constantin Anghel
Andrei Constantin Anghel
DADarie-Ioan Andreescu
Darie-Ioan Andreescu
Alexandru DeaconuAlexandru Deaconu
Alexandru Deaconu
Background: Patients with end-stage renal disease (ESRD) are at elevated risk for device-related complications following pacemaker implantation. Leadless pacemakers (LPMs) offer theoretical advantages over transvenous pacemakers (TVPs), but their safety and efficacy in this high-risk population remain unclear. Our aim was to compare clinical outcomes and complication profiles between leadless and transvenous pacemakers in patients with ESRD. Methods: We conducted a systematic review and meta-analysis according to PRISMA guidelines, including three retrospective studies comparing LPMs and TVPs in ESRD patients. The primary endpoint was overall complications post-implantation. Secondary outcomes included early mortality (within 30 days), access site complications, device-related events, thrombotic events, and respiratory complications. A random-effects model was used to pool odds ratios (ORs) and 95% confidence intervals (CIs). Results: Three studies comprising 10.075 ESRD patients were included. No significant difference was found in overall complications (OR 1.35, 95% CI 0.78–2.33, p = 0.14) or early mortality (OR 1.01, 95% CI 0.42–2.43, p = 0.97) between LPM and TVP groups. However, LPMs were associated with increased access site complications (OR 2.51, 95% CI 1.06–5.90, p = 0.04), thrombotic events (OR 1.42, 95% CI 1.14–1.78, p = 0.03), and respiratory complications (OR 1.43, 95% CI 1.01–2.03, p = 0.05). Device-related complication rates were similar (OR, 1.09; 95% CI, 0.63–1.88; p = 0.30). Heterogeneity was low across most outcomes. Conclusions: Among patients with ESRD, leadless pacemakers did not reduce overall complications or short-term mortality compared to transvenous systems and were associated with increased risk of certain procedural complications. These findings could support a personalized approach to device selection in ESRD and highlight the need for further prospective studies to guide clinical decision-making in this population.

18 July 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
AAAlexandru Ababei
Alexandru Ababei
Cosmin Gabriel UrsuCosmin Gabriel Ursu
Cosmin Gabriel Ursu
Mircea Ioan Alexandru BistriceanuMircea Ioan Alexandru Bistriceanu
Mircea Ioan Alexandru Bistriceanu
DADarie-Ioan Andreescu
Darie-Ioan Andreescu
IIIasmina Maria Iurea
Iasmina Maria Iurea
SBStefan Bogdan
Stefan Bogdan
Background: When conservative therapies are insufficient for vasovagal syncope (VVS), procedural options such as permanent pacemakers or catheter ablation of ganglionated plexi (GP) may be considered. This meta-analysis aimed to evaluate the efficacy of GP catheter ablation in patients with VVS. Methods: A comprehensive literature search was performed in PubMed, Embase, and the Cochrane Library from 15 March 2024 to 10 May 2025. After duplicate removal, two reviewers independently screened studies and assessed full texts based on predefined criteria. A single-arm proportion meta-analysis was conducted. Results: Thirty-seven studies comprising 1585 participants were included. The pooled proportion of VVS recurrence after ablation was 8.9% (95% CI, 6.4–11.4%), but with substantial heterogeneity (I2 = 74.4%, p < 0.001). Sensitivity and subgroup analyses confirmed the robustness of the pooled estimate. A meta-regression was performed to further explore potential effect modifiers, but no covariate reached statistical significance. Conclusions: This meta-analysis suggests that ganglionated plexi catheter ablation may be associated with a reduced recurrence of vasovagal syncope in selected populations. However, the findings are based predominantly on non-randomized observational studies, and the high between-study heterogeneity limits the strength of inference. Future randomized controlled trials with standardized methodologies are needed to confirm the long-term efficacy and safety of this intervention.

30 March 2025 in Medicina
Verified
Journal Article
Open access
PDF file
DTDragoș Trache
Dragoș Trache
LSLiviu Ionut Serbanoiu
Liviu Ionut Serbanoiu
Mircea Ioan Alexandru BistriceanuMircea Ioan Alexandru Bistriceanu
Mircea Ioan Alexandru Bistriceanu
GOGabriel Olteanu
Gabriel Olteanu
OAOctavian Andronic
Octavian Andronic
Stefan Sebastian BusnatuStefan Sebastian Busnatu
Stefan Sebastian Busnatu
This narrative review aims to evaluate the current evidence on the use of cardiac telerehabilitation (CTR) in patients after myocardial infarction, focusing on the effectiveness of e-learning platforms and remote monitoring for addressing cardiovascular risk factors, improving physical fitness, and enhancing patient adherence. The review also explores the limitations and gaps in the literature, highlighting the need for future research to optimize CTR approaches. A comprehensive literature search was conducted using PubMed and Scopus, focusing on specific keywords. The search yielded fifteen randomized controlled trials. Data from these studies were analyzed to evaluate the methodology, interventions, patient characteristics, and outcomes related to the use of CTR in managing cardiovascular risk factors and improving physical fitness. The included studies demonstrated that CTR interventions, delivered via online platforms, phone calls, and smart devices, were effective in improving cardiovascular risk factors, physical activity levels, and overall patient satisfaction. CTR appears to be associated with improvements in exercise tolerance, VO2 max, body composition, and adherence. While the outcomes were promising, there is still limited evidence regarding the long-term impact of CTR on cardiovascular risk factors and lifestyle interventions, particularly in non-exercise components like dietary management and psychological support. Cardiac telerehabilitation presents a feasible and effective alternative to traditional in-hospital rehabilitation programs for patients recovering from myocardial infarction. The integration of e-learning platforms and smart devices enhances patient adherence, improves cardiovascular risk factors, and increases access to rehabilitation services, particularly for those who face barriers to traditional care. However, further large-scale studies are needed to establish standardized protocols and best practices for CTR. Additionally, future research should address disparities in access to digital health technologies, especially among rural and underserved populations, to ensure equitable access to these innovative approaches.

18 February 2026 in Heart Rhythm O2
Verified
Journal Article
Open access
ADAlexandru Deaconu
Alexandru Deaconu
Mircea Ioan Alexandru BistriceanuMircea Ioan Alexandru Bistriceanu
Mircea Ioan Alexandru Bistriceanu
SDSilvia Deaconu
Silvia Deaconu
OMObaida Makdah
Obaida Makdah
CUCosmin Gabriel Ursu
Cosmin Gabriel Ursu
RVRadu Gabriel Vătăşescu
Radu Gabriel Vătăşescu
Conduction system pacing (CSP), including His bundle pacing and left bundle branch pacing, has emerged as a physiological alternative to right ventricular pacing (RVP) for patients developing conduction disturbances after transcatheter aortic valve replacement. We performed a systematic review and meta-analysis to compare CSP with RVP. PubMed, Embase, and Cochrane databases were searched according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A random-effects model was used for all outcomes, and heterogeneity was assessed using I2 statistics. The protocol was registered in PROSPERO (CRD420251125169). 8 studies, including 784 patients, were analyzed. At 15-month follow-up, all-cause mortality did not differ significantly between CSP (left bundle branch pacing in 74%) and RVP (odds ratio 0.76; 95% confidence interval [CI] 0.51-1.14; P = .15; I2 = 0%). CSP was associated with a shorter paced QRS duration after implant (mean difference -34.6 ms; 95% CI -40.2 to -29.1; P < .001) and higher left ventricular ejection fraction (mean difference +5.4%; 95% CI 3.5-7.3; P = .003) at 15-month follow-up. Heart failure hospitalization at 15 months was associated with a reduction in CSP (odds ratio 0.44; 95% CI 0.27-0.72; P = .006), whereas cardiovascular mortality, sensing, impedance, and lead dislodgement were similar between pacing strategies. These findings suggest that CSP provides more physiological ventricular activation and may improve functional outcomes after transcatheter aortic valve replacement without affecting overall survival. Further randomized studies are warranted to confirm these observations.

9 March 2026 in Life
Verified
Journal Article
Open access
PDF file
GCGherghin Alina Claudia
Gherghin Alina Claudia
Mircea Ioan Alexandru BistriceanuMircea Ioan Alexandru Bistriceanu
Mircea Ioan Alexandru Bistriceanu
Onu IlieOnu Ilie
Onu Ilie
Daniel-Andrei IordanDaniel-Andrei Iordan
Daniel-Andrei Iordan
FDFlorentin Dimofte
Florentin Dimofte
ASAlexandru Scafa-Udriste
Alexandru Scafa-Udriste
Cardiac telerehabilitation has become a promising alternative to traditional programmes for preventing acute coronary syndrome (ACS) in the secondary phase. However, current implementations are still reactive and standardised, lacking personalisation and flexibility in clinical settings. By integrating artificial intelligence (AI), it may be possible to overcome these limitations and provide intelligent, scalable, and patient-centred care. Methods: We conducted a structured literature review across PubMed, Scopus, the Cochrane Library, and Web of Science, targeting English-language studies published from January 2015 to May 2025. Inclusion criteria included adult populations with a history of ACS or high cardiovascular risk, assessing interventions based on AI, telerehabilitation, or their combination. Studies are needed to report clinical, functional, behavioural, or technological outcomes. A thematic narrative synthesis was utilised. Results: AI-enhanced telerehabilitation demonstrates potential advantages over conventional digital care in selected domains, including adaptive risk prediction, personalised exercise modulation, and adherence support. Several systems report real-time adjustment of exercise protocols, early dropout detection, and predictive analytics for rehospitalisation. AI integration may also contribute to personalised behavioural feedback and psychosocial monitoring. Nevertheless, the overall level of evidence remains preliminary and heterogeneous, with most AI-based interventions evaluated in pilot, feasibility, or modelling studies rather than large-scale randomized trials. Conclusions: The integration of AI into telerehabilitation represents a promising evolution in post-ACS care, shifting from predominantly reactive monitoring toward more adaptive and data-driven support models. While early-phase studies suggest feasibility and potential clinical benefit, robust multicentre randomized controlled trials and cost-effectiveness analyses are required before definitive conclusions regarding superiority or widespread implementation can be drawn.

18 January 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
LCLiviu Stefan Calin
Liviu Stefan Calin
DADarie-Ioan Andreescu
Darie-Ioan Andreescu
Mircea Ioan Alexandru BistriceanuMircea Ioan Alexandru Bistriceanu
Mircea Ioan Alexandru Bistriceanu
Cosmin Gabriel UrsuCosmin Gabriel Ursu
Cosmin Gabriel Ursu
AAAndrei Constantin Anghel
Andrei Constantin Anghel
Stefan Sebastian BusnatuStefan Sebastian Busnatu
Stefan Sebastian Busnatu
Background/Objectives: Cardiac rehabilitation (CR) is known to improve clinical outcomes in cardiovascular disease, yet its benefits in patients with implantable cardioverter-defibrillators (ICD) are not well established. This meta-analysis evaluated the impact of CR on functional capacity and safety in ICD recipients. Methods: A systematic search of PubMed, Scopus, and Cochrane Library was performed to identify randomized controlled trials (RCT) involving adults who underwent ICD implantation and were assigned to either CR or standard care. The primary outcome was the change in peak oxygen uptake (peak VO2) from the baseline to the final follow-up. Random-effects models were applied, and subgroup analyses were conducted based on follow-up duration, supervision type, baseline peak VO2, and ischemic vs. non-ischemic etiology. Results: Seven RCTs involving 1461 participants (784 CR; 677 control) met the inclusion criteria. CR was associated with a significant improvement peak VO2 compared with usual care, expressed as the mean difference (MD) in change from the baseline to the last follow-up (MD 2 mL·kg−1·min−1; 95% CI 1.02–2.81; I2 = 65.7%), with consistent effects across all subgroups. Quality of life improved in the CR group (MD 6.46; 95% CI 2.25–10.67; I2 = 0%). A non-significant trend toward increased 6MWT distance was observed. CR did not increase adverse events, including ICD shocks, hospitalizations, or cardiac deaths. Conclusions: CR safely enhances exercise capacity and quality of life in ICD recipients without increasing arrhythmic events or mortality. Larger standardized trials are warranted to optimize CR delivery in this population.